Ā | Overall | ICU | HDU |
---|---|---|---|
nā=ā10,818 | nā=ā6584 (60.9%) | nā=ā4234 (39.1%) | |
Vasoactive agents | |||
Ā Dopamine, n (%) | 2168 (20.0) | 1413 (21.5%) | 755 (17.8) |
Ā Adrenaline, n (%) | 982 (9.1) | 720 (10.9%) | 262 (6.2) |
Ā Dobutamine, n (%) | 868 (8.0) | 649 (9.9%) | 219 (5.2) |
Ā Vasopressin, n (%) | 1875 (17.3) | 1479 (22.5%) | 396 (9.4) |
Ā ā„2 drugs, n (%) | 4459 (41.2) | 3146 (47.8%) | 1313 (31.0) |
Ā ā„3 drugs, n (%) | 1193 (11.0) | 924 (14.0%) | 269 (6.4) |
Transfusion | |||
Ā Red blood cell, n (%) | 1805 (16.7) | 1404 (21.3) | 401 (9.5) |
Ā Platelet, n (%) | 667 (6.2) | 521 (7.9) | 146 (3.5) |
Ā Fresh frozen plasma, n (%) | 1581 (14.6) | 1300 (19.7) | 281 (6.6) |
Albumin, n (%) | 3226 (29.8) | 2403 (36.5) | 823 (19.4) |
Globulin, n (%) | 1511 (14.0) | 1105 (16.8) | 406 (9.6) |
Recombinant thrombomodulin, n (%) | 2169 (20.1) | 1281 (19.5) | 888 (21.0) |
Antithrombin III, n (%) | 1108 (10.2) | 827 (12.6) | 281 (6.6) |
Hydrocortisone, n (%) | 2706 (25.0) | 1922 (29.2) | 784 (18.5) |
Sedative drugs, n (%) | 5796 (53.6) | 4325 (65.7) | 1471 (34.7) |
Narcotic drugs, n (%) | 4562 (42.2) | 3481 (52.9) | 1081 (25.5) |
Prophylaxis of gastrointestinal ulcer, n (%) | 6327 (58.5) | 4470 (67.9) | 1857 (43.9) |
Prophylaxis of deep vein thrombosis, n (%) | 3916 (36.2) | 2762 (42.0) | 1154 (27.3) |
Rehabilitation, n (%) | 516 (4.8) | 469 (7.1) | 47 (1.1) |
Mechanical ventilation, n (%) | 4049 (37.4) | 2986 (45.4) | 1063 (25.1) |
CRRT, n (%) | 1691 (15.6) | 1351 (20.5) | 340 (8.0) |
PMX-DHP, n (%) | 1025 (9.5) | 746 (11.3) | 279 (6.6) |
VA-ECMO/IABP, n (%) | 200 (1.9) | 172 (2.6) | 28 (0.7) |
Central venous catheter, n (%) | 7087 (65.5) | 5028 (76.4) | 2059 (48.6) |
Arterial line, n (%) | 6979 (64.5) | 5159 (78.4) | 1820 (43.0) |
Urinary catheter, n (%) | 8237 (76.1) | 5109 (77.6) | 3128 (73.9) |
Nasogastric tube, n (%) | 4449 (41.1) | 3406 (51.7) | 1043 (24.6) |
Blood culture test, n (%) | 9571 (88.5) | 5799 (88.1) | 3772 (89.1) |
Antibiotics | |||
Ā Penicillin, n (%) | 3459 (32.0) | 2087 (31.7) | 1372 (32.4) |
Ā Cephalosporin, n (%) | 2566 (23.7) | 1554 (23.6) | 1012 (23.9) |
Ā Carbapenem, n (%) | 5896 (54.5) | 3683 (55.9) | 2213 (52.3) |
Ā Quinolone, n (%) | 500 (4.6) | 361 (5.5) | 139 (3.3) |
Ā Anti-MRSA, n (%) | 1484 (13.7) | 1102 (16.7) | 382 (9.0) |
Ā Aminoglycoside, n (%) | 208 (1.9) | 119 (1.8) | 89 (2.1) |
Ā Metronidazole, n (%) | 116 (1.1) | 90 (1.4) | 26 (0.6) |
Ā Anti-fungal, n (%) | 180 (1.7) | 137 (2.1) | 43 (1.0) |
Ā Anti-viral, n (%) | 248 (2.3) | 176 (2.7) | 72 (1.7) |
Drainage | |||
Ā Endoscopic, n (%) | 357 (3.3) | 178 (2.7) | 179 (4.2) |
Ā Percutaneous, n (%) | 214 (2.0) | 127 (1.9) | 87 (2.1) |
Ā Urinary, n (%) | 754 (7.0) | 388 (5.9) | 366 (8.8) |
Surgery | |||
Ā Abdominal surgery, n (%) | 1583 (14.6) | 1207 (18.3) | 376 (8.9) |
Ā Limb surgery, n (%) | 92 (0.9) | 67 (1.0) | 25 (0.6) |